Renal cancer is the disease in which certain tissues of the kidney starts to grow uncontrollably and form a tumor.

It is also called as renal adenocarcinoma or hypernephroma.

Classic triad of symptoms are flank pain, palpable abdominal mass and gross hematuria.

Surgical Intervention

  • The preferred treatment for renal cell carcinoma
  • The choice of surgical procedure depends on the extent of the disease, as well as patient-specific factors such as age and comorbidity
  • May be carried out through a conventional approach or by a minimally-invasive approach

Partial Nephrectomy or Nephron-Sparing Surgery (NSS)

  • Indicated in patients with solitary kidney, one kidney with contralateral renal function and bilateral synchronous renal cell carcinoma (RCC)
  • May also be considered in young patients or those with comorbidities at relative risk for progressive chronic renal disease 
  • Preferred surgical management for patients with stage I (pT1a, pT1b)
  • Only the diseased or injured portion of the kidney is removed
  • Contraindicated in patients with locally advanced tumor growth, tumor in an unfavorable location, or with confirmed nodal metastases

Radical Nephrectomy

  • The most widely used approach and the preferred procedure if there is evidence of invasion into the adrenal gland, renal vein or perinephric fat
  • Involves the removal of the entire kidney along with a section of the tube leading to the bladder, ureter, adrenal gland and fatty tissues surrounding the kidney
  • Preferred surgical management for patients with stage II-III
  • With increased risk for chronic kidney disease and cardiovascular morbidity and mortality compared to NSS

Ablative Techniques


  • Indicated for <3 cm solitary renal tumor located away from the collecting system

Microwave Ablation

  • Indicated for frail patients at high surgical risk with ≤3 cm solitary renal tumor, renal impairment, hereditary RCC or multiple bilateral tumors

Radiofrequency Ablation

  • An alternative treatment in patients with contraindications to nephrectomy, Von Hippel-Lindau disease and unfit elderly patients
  • Creates molecular friction, denaturation of cellular proteins and cell membrane disintegration
  • Heat-based tissue destruction with a high-frequency electrical current (400 to 500 kHz)

Other Procedures


  • Considered in patients with large upper pole tumors or abnormal-appearing adrenal glands on CT scan and must be decided on an individual basis

Cytoreductive or Debulking Nephrectomy

  • Mostly involves the removal of the primary tumor from the kidney
  • Recommended in patients with good performance [Eastern Cooperative Oncology Group (ECOG) performance status <2] preceding systemic therapy and no brain metastasis
  • May be considered in patients with stage IV or relapsed disease if primary tumor is surgically resectable


  • The lungs, bones, brain and liver are the most common sites of metastasis
  • Patients with stage IV disease may be considered for metastasectomy if:
    • Primary RCC and oligometastatic sites (includes lung, bone, brain) present upon initial diagnosis
    • Patient develops oligometastases after prolonged disease-free interval after nephrectomy

Regional Lymph Node Dissection

  • May be considered in patients with enlarged or palpable lymph nodes seen in preoperative imaging tests

Risks and Side Effects of Surgery

  • Short-term risks includes reactions to anesthesia, excess bleeding (may require blood transfusions), blood clots and infections
  • Damage to internal organs and blood vessels (spleen, pancreas, aorta, vena cava, large or small bowel) during surgery
  • Leakage of urine into the abdomen (after partial nephrectomy)
  • Kidney failure (if the remaining kidney fails to function well)

Palliative Surgery

  • For management of spinal cord compression or possible/confirmed fractures in weight-bearing bones in select patients
Editor's Recommendations
Most Read Articles
10 Jan 2021
Regular practice of yoga postures confers benefits for glucose control, oxidative stress, inflammatory response, and sleep quality in patients with type 2 diabetes, a study has found.
01 Dec 2020
Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, pertussis toxoid 2.5 mcg, filamentous haemagglutinin 5 mcg, fimbriae types 2 and 3 5 mcg, pertactin 3 mcg
Dr. Hsu Li Yang, Dr. Tan Thuan Tong, Dr. Andrea Kwa, 08 Jan 2021
Antimicrobial resistance has become increasingly dire as the rapid emergence of drug resistance, especially gram-negative pathogens, has outpaced the development of new antibiotics. At a recent virtual symposium, Dr Hsu Li Yang, Vice Dean (Global Health) and Programme Leader (Infectious Diseases), NUS Saw Swee Hock School of Public Health, presented epidemiological data on multidrug-resistant (MDR) gram-negative bacteria (GNB) in Asia, while Dr Tan Thuan Tong, Head and Senior Consultant, Department of Infectious Diseases, Singapore General Hospital (SGH), focused on the role of ceftazidime-avibactam in MDR GNB infections. Dr Andrea Kwa, Assistant Director of Research, Department of Pharmacy, SGH, joined the panel in an interactive fireside chat, to discuss challenges, practical considerations, and solutions in MDR gram-negative infections. This Pfizer-sponsored symposium was chaired by Dr Ng Shin Yi, Head and Senior Consultant of Surgical Intensive Care, SGH.
Pearl Toh, 26 Nov 2020
Inhaled corticosteroid (ICS) should be the mainstay of long-term asthma management — such is the key message of the latest Singapore ACE* Clinical Guidance (ACG) for asthma, released in October 2020.